Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2022 Mar 8

PMID 35256842

Authors

Yingda Lin

Fuming He

Ling Wu

Yuan Xu

Qiu Du

Affiliations

Soon will be listed here.

Abstract

As The main effective monomer of the traditional Chinese medicine , matrine has a broad scope of pharmacological activities such as anti-tumor, anti-inflammatory, analgesic, anti-fibrotic, anti-viral, anti-arrhythmia, and improving immune function. These actions explain its therapeutic effects in various types of tumors, cardiopathy, encephalomyelitis, allergic asthma, rheumatoid arthritis (RA), osteoporosis, and central nervous system (CNS) inflammation. Evidence has shown that the mechanism responsible for the pharmacological actions of matrine may be via the activation or inhibition of certain key molecules in several cellular signaling pathways including the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR), transforming growth factor-β/mothers against decapentaplegic homolog (TGF-β/Smad), nuclear factor kappa B (NF-κB), Wnt (wingless/ integration 1)/β-catenin, mitogen-activated protein kinases (MAPKs), and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathways. This review comprehensively summarizes recent studies on the pharmacological mechanisms of matrine to provide a theoretical basis for molecular targeted therapies and further development and utilization of matrine.

Citing Articles

Natural products for the treatment of ulcerative colitis: focus on the JAK/STAT pathway.

Long D, Mao C, Zhang W, Zhu Y, Xu Y Front Immunol. 2025; 16:1538302.

PMID: 40078988 PMC: 11897526. DOI: 10.3389/fimmu.2025.1538302.

Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions.

Lu Y, Zhang X, Guan Z, Ji R, Peng F, Zhao C Parasite. 2025; 32:7.

PMID: 39902829 PMC: 11792522. DOI: 10.1051/parasite/2025001.

Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway.

Wu J, Li K, Zhou M, Gao H, Wang W, Xiao W J Pharm Anal. 2024; 14(8):100946.

PMID: 39258172 PMC: 11386058. DOI: 10.1016/j.jpha.2024.01.014.

Natural Bioactive Compounds in the Management of Periodontal Diseases: A Comprehensive Review.

Hashim N, Babiker R, Rahman M, Mohamed R, Priya S, Chaitanya N Molecules. 2024; 29(13).

PMID: 38998994 PMC: 11242977. DOI: 10.3390/molecules29133044.

An insight into the anticancer potentials of lignan arctiin: A comprehensive review of molecular mechanisms.

Chowdhury R, Bhuia M, Wilairatana P, Afroz M, Hasan R, Ferdous J Heliyon. 2024; 10(12):e32899.

PMID: 38988539 PMC: 11234030. DOI: 10.1016/j.heliyon.2024.e32899.

References

Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X . Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019; 18(1):26. PMC: 6379961. DOI: 10.1186/s12943-019-0954-x. View

Liu J, Zhang L, Ren Y, Gao Y, Kang L, Lu S . Matrine inhibits the expression of adhesion molecules in activated vascular smooth muscle cells. Mol Med Rep. 2016; 13(3):2313-9. DOI: 10.3892/mmr.2016.4767. View

Wagner E, Nebreda A . Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009; 9(8):537-49. DOI: 10.1038/nrc2694. View

Chi G, Xu D, Zhang B, Yang F . Matrine induces apoptosis and autophagy of glioma cell line U251 by regulation of circRNA-104075/BCL-9. Chem Biol Interact. 2019; 308:198-205. DOI: 10.1016/j.cbi.2019.05.030. View

Ma Y, Zou F, Xiong J, Wan W, Yin L, Li X . Effect of Matrine on HPAC cell migration by down-regulating the expression of MT1-MMP via Wnt signaling. Cancer Cell Int. 2015; 15:59. PMC: 4480578. DOI: 10.1186/s12935-015-0210-4. View

Ren H, Zhang S, Ma H, Wang Y, Liu D, Wang X . Matrine reduces the proliferation and invasion of colorectal cancer cells via reducing the activity of p38 signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2014; 46(12):1049-55. DOI: 10.1093/abbs/gmu101. View

Huang H, Wang Q, Du T, Lin C, Lai Y, Zhu D . Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B. Prostate. 2018; 78(5):327-335. DOI: 10.1002/pros.23469. View

Yang Z, Wang L, Wang X . Matrine induces the hepatic differentiation of WB-F344 rat hepatic progenitor cells and inhibits Jagged 1/HES1 signaling. Mol Med Rep. 2016; 14(4):3841-7. DOI: 10.3892/mmr.2016.5668. View

Yin H, Que R, Liu C, Ji W, Sun B, Lin X . Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma. Cancer Lett. 2018; 425:54-64. DOI: 10.1016/j.canlet.2018.03.044. View

10.

Zhao L, Cai H, Tang Z, Cui Q, Liu Z, Lu S . Matrine suppresses advanced glycation end products-induced human coronary smooth muscle cells phenotype conversion by regulating endoplasmic reticulum stress-dependent Notch signaling. Eur J Pharmacol. 2020; 882:173257. DOI: 10.1016/j.ejphar.2020.173257. View

11.

Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y . Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Cancer Lett. 2015; 368(1):126-134. DOI: 10.1016/j.canlet.2015.07.035. View

12.

Li J, Xu J, Lu Y, Qiu L, Xu W, Lu B . MASM, a Matrine Derivative, Offers Radioprotection by Modulating Lethal Total-Body Irradiation-Induced Multiple Signaling Pathways in Wistar Rats. Molecules. 2016; 21(5). PMC: 6273364. DOI: 10.3390/molecules21050649. View

13.

Jiang J, Wang G . Matrine protects PC12 cells from lipopolysaccharide-evoked inflammatory injury via upregulation of miR-9. Pharm Biol. 2020; 58(1):314-320. PMC: 7178860. DOI: 10.1080/13880209.2020.1719165. View

14.

Cai X, Guo H, Xie B . Structural Modifications of Matrine-Type Alkaloids. Mini Rev Med Chem. 2016; 18(9):730-744. DOI: 10.2174/1389557516666161104150334. View

15.

Ma L, Xu Z, Wang J, Zhu Z, Lin G, Jiang L . Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells. Oncotarget. 2018; 8(65):108880-108889. PMC: 5752489. DOI: 10.18632/oncotarget.22353. View

16.

Chen X, Zhi X, Pan P, Cui J, Cao L, Weng W . Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB J. 2017; 31(11):4855-4865. PMC: 5636701. DOI: 10.1096/fj.201700316R. View

17.

Sun P, Sun N, Yin W, Sun Y, Fan K, Guo J . Matrine inhibits IL-1β secretion in primary porcine alveolar macrophages through the MyD88/NF-κB pathway and NLRP3 inflammasome. Vet Res. 2019; 50(1):53. PMC: 6626430. DOI: 10.1186/s13567-019-0671-x. View

18.

Xie M, Yi X, Wang R, Wang L, He G, Zhu M . 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro. Cell Physiol Biochem. 2014; 33(5):1475-83. DOI: 10.1159/000358712. View

19.

Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G . Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology. 2009; 59(3):219-29. PMC: 2774574. DOI: 10.1007/s10616-009-9225-9. View

20.

Ma X, Chen R, Liu X, Xie J, Si K, Duan L . Effects of matrine on JAK-STAT signaling transduction pathways in bleomycin-induced pulmonary fibrosis. Afr J Tradit Complement Altern Med. 2013; 10(3):442-8. PMC: 3777585. DOI: 10.4314/ajtcam.v10i3.10. View